# SPRR1A

## Overview
SPRR1A (small proline-rich protein 1A) is a gene that encodes a member of the small proline-rich protein family, which is characterized by a high proline content. The protein encoded by SPRR1A plays a crucial role in the structural integrity of epithelial tissues, contributing to the formation of the cornified cell envelope through its repetitive sequences and post-translational modifications (Deng2000Distinct). Beyond its structural role, SPRR1A is involved in various cellular processes, including neuronal regeneration and cardiac remodeling. In neurons, SPRR1A is upregulated following axonal injury, promoting axonal outgrowth and regeneration (Bonilla2002Small). In the cardiac context, it acts as a downstream effector of miR-150, influencing cardiac fibroblast activation and fibrosis, particularly following myocardial infarction (Kawaguchi2023SPRR1A). Additionally, SPRR1A exhibits antimicrobial activity, contributing to the defense of the cutaneous barrier (Zhang2021Small). Its involvement in these diverse biological processes underscores its potential as a therapeutic target in conditions such as cardiac fibrosis and certain cancers.

## Structure
SPRR1A, a member of the small proline-rich protein family, is characterized by a high proline content, which contributes to its structural role in epithelial tissues. The primary structure of SPRR1A includes repetitive sequences, which are typical for proteins involved in forming the cornified cell envelope. These repetitive sequences are crucial for the protein's function in providing structural integrity to epithelial cells (Deng2000Distinct).

The secondary structure of SPRR1A may include beta-turns, a common feature due to the conformational constraints imposed by proline residues. These beta-turns are important for the protein's ability to form stable structures within the cell envelope (Deng2000Distinct).

SPRR1A undergoes several post-translational modifications, which enhance its function in barrier formation. These modifications include phosphorylation and cross-linking with other proteins such as loricrin and involucrin. The cross-linking is facilitated by transglutaminase enzymes, which prefer specific glutamine clusters in the amino-terminal region of SPRR1A for forming cross-links, playing a significant role in the formation of cornified envelopes (Deng2000Distinct).

The protein's structure and modifications are essential for its role in the terminal differentiation of epithelial cells, although the specific mechanisms remain to be fully elucidated (Deng2000Distinct).

## Function
SPRR1A (small proline-rich protein 1A) plays a significant role in neuronal and cardiac functions. In neurons, SPRR1A is upregulated following axonal injury and is involved in promoting axonal outgrowth and regeneration. It is localized in neuronal cell bodies and axonal processes, suggesting its transport throughout regenerating axons. SPRR1A is associated with F-actin-rich structures in axonal growth cones, indicating a role in modulating cytoskeletal dynamics to influence axonal growth cone motility (Bonilla2002Small).

In cardiac fibroblasts, SPRR1A is a key downstream effector of miR-150, involved in maladaptive cardiac remodeling and fibroblast activation. Its expression is upregulated post-myocardial infarction, contributing to cardiac fibrosis by promoting fibroblast proliferation and migration. SPRR1A knockdown reduces the expression of profibrotic markers and attenuates adverse cardiac remodeling, highlighting its role in fibrotic processes (Kawaguchi2023SPRR1A).

SPRR1A is primarily active in the cytoplasm and cell membrane, where it contributes to cellular differentiation and response to stress, aiding in processes such as wound healing and protection against environmental damage (Bonilla2002Small).

## Clinical Significance
Alterations in the expression of the SPRR1A gene have been implicated in various diseases, particularly in cardiac and cancer-related conditions. In the context of cardiac health, SPRR1A is a key downstream effector of miR-150, a microRNA with protective roles in the heart. Downregulation of miR-150 leads to increased SPRR1A expression, which is associated with maladaptive cardiac remodeling, increased fibrosis, and impaired ventricular function following myocardial infarction (MI). Knockdown of SPRR1A in miR-150 knockout models has been shown to reduce cardiac fibrosis and improve cardiac outcomes, suggesting its potential as a therapeutic target for heart failure and cardiac fibrosis (Kawaguchi2023SPRR1A).

In cancer, SPRR1A expression is linked to poor prognosis in several types. High SPRR1A expression is associated with increased proliferation, migration, and chemotherapy resistance in pancreatic ductal adenocarcinoma, contributing to poor clinical outcomes (Yamakawa2022Increased). Similarly, in colon cancer, elevated SPRR1A levels correlate with lymph node invasion and worse survival rates, marking it as an independent prognostic factor (Deng2020High). In head and neck squamous cell carcinoma, SPRR1A is part of a three-gene model that predicts patient survival, with its expression levels helping to stratify patients into different prognostic groups (Pavón2019The).

## Interactions
SPRR1A interacts with various proteins and is involved in several cellular processes. It is highly concentrated in F-actin-rich structures, such as dorsal and leading edge ruffles, but does not directly bind to F-actin. Instead, SPRR1A is suggested to bind to actin-associated proteins enriched in these ruffles, indicating a role in modulating F-actin structures crucial for axonal growth cone motility (Bonilla2002Small). SPRR1A also colocalizes with S100C in these ruffles, suggesting a potential collaborative role in these subcellular structures (Bonilla2002Small).

In the context of cardiac remodeling, SPRR1A is identified as a downstream effector of miR-150. The interaction between miR-150 and SPRR1A is crucial for regulating cardiac fibroblast activation and fibrosis. miR-150 inhibits the profibrotic effects of SPRR1A, and its absence leads to increased cardiac fibrosis and damage. SPRR1A knockdown reduces cardiac fibroblast proliferation and migration, highlighting its role in cardiac fibrosis (Kawaguchi2023SPRR1A).

SPRR1A is also involved in the defense of the cutaneous barrier through its interaction with negatively charged lipid membranes, exhibiting antimicrobial activity against various bacterial species (Zhang2021Small). These interactions underscore SPRR1A's multifaceted role in cellular processes and its potential as a therapeutic target.


## References


[1. (Bonilla2002Small) Iris E. Bonilla, Katsuhisa Tanabe, and Stephen M. Strittmatter. Small proline-rich repeat protein 1a is expressed by axotomized neurons and promotes axonal outgrowth. The Journal of Neuroscience, 22(4):1303–1315, February 2002. URL: http://dx.doi.org/10.1523/jneurosci.22-04-01303.2002, doi:10.1523/jneurosci.22-04-01303.2002. This article has 240 citations.](https://doi.org/10.1523/jneurosci.22-04-01303.2002)

[2. (Yamakawa2022Increased) Kohei Yamakawa, Michiyo Koyanagi-Aoi, Keiichiro Uehara, Atsuhiro Masuda, Hiroaki Yanagimoto, Hirochika Toyama, Takumi Fukumoto, Yuzo Kodama, and Takashi Aoi. Increased expression of sprr1a is associated with a poor prognosis in pancreatic ductal adenocarcinoma. PLOS ONE, 17(5):e0266620, May 2022. URL: http://dx.doi.org/10.1371/journal.pone.0266620, doi:10.1371/journal.pone.0266620. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0266620)

[3. (Deng2020High) Yu Deng, Xin Zheng, Yiyi Zhang, Meifang Xu, Chengwei Ye, Mengxin Lin, Jie Pan, Zongbin Xu, Xingrong Lu, and Pan Chi. High sprr1a expression is associated with poor survival in patients with colon cancer. Oncology Letters, March 2020. URL: http://dx.doi.org/10.3892/ol.2020.11453, doi:10.3892/ol.2020.11453. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2020.11453)

4. (Zhang2021Small) Small proline-rich proteins (SPRRs) are epidermally produced antimicrobial proteins that defend the cutaneous barrier by direct bacterial membrane disruption. This article has 1 citations.

[5. (Deng2000Distinct) Jun Deng, Ruiqin Pan, and Reen Wu. Distinct roles for amino- and carboxyl-terminal sequences of sprr1 protein in the formation of cross-linked envelopes of conducting airway epithelial cells. Journal of Biological Chemistry, 275(8):5739–5747, February 2000. URL: http://dx.doi.org/10.1074/JBC.275.8.5739, doi:10.1074/jbc.275.8.5739. This article has 8 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.275.8.5739)

[6. (Kawaguchi2023SPRR1A) Satoshi Kawaguchi, Bruno Moukette, Marisa N. Sepúlveda, Taiki Hayasaka, Tatsuya Aonuma, Angela K. Haskell, Jessica Mah, Suthat Liangpunsakul, Yaoliang Tang, Simon J. Conway, and Il-man Kim. Sprr1a is a key downstream effector of mir-150 during both maladaptive cardiac remodeling in mice and human cardiac fibroblast activation. Cell Death &amp; Disease, July 2023. URL: http://dx.doi.org/10.1038/s41419-023-05982-y, doi:10.1038/s41419-023-05982-y. This article has 2 citations.](https://doi.org/10.1038/s41419-023-05982-y)

[7. (Pavón2019The) Miguel Angel Pavón, Irene Arroyo‐Solera, Xavier León, Marta Téllez‐Gabriel, David Virós, Alberto Gallardo, Maria Virtudes Céspedes, Isolda Casanova, Antonio Lopez‐Pousa, Agustí Barnadas, Miquel Quer, and Ramón Mangues. The combined use of efs, gpx2, and sprr1a expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes. Head &amp; Neck, 41(6):1830–1845, January 2019. URL: http://dx.doi.org/10.1002/hed.25623, doi:10.1002/hed.25623. This article has 10 citations.](https://doi.org/10.1002/hed.25623)